Concepedia

Jose M. Mateos Rodriguez

JM

4

Publications

60

Citations

4

H-Index

1987

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Institute of Cancer Research

Royal Marsden Hospital

Jose M. Mateos Rodriguez is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pathology, and cancer research.

Top concepts

Publications per year

1987–2020

4

Publications

4

Su1828 Remission in Proton Pump Inhibitors-Responsive Esophageal Eosinophilia Correlates With Downregulation of Eotaxin-3 and TH2 Cytokines, Similarly to Eosinophilic Esophagitis After Steroids

Javier Molina‐Infante, María Dolores Megías Rivas, Gema Vinagre Rodríguez et al. · Gastroenterology · 2013 · 21 citations

, , +9

Pembrolizumab (pembro) plus olaparib in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A efficacy, safety, and biomarker results.

Evan Y. Yu, Jose M. Mateos Rodriguez, Gwénaëlle Gravis et al. · Journal of Clinical Oncology · 2020 · 14 citations

, , +18

Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC).

Emmanuel S. Antonarakis, Jose M. Mateos Rodriguez, Marine Gross‐Goupil et al. · Journal of Clinical Oncology · 2020 · 14 citations

, , +22

[Preventing the recurrence of febrile seizures: intermittent prevention with rectal diazepam compared with continuous treatment with sodium valproate].

Cipriano De Mosquera, Jose M. Mateos Rodriguez, A Fernández Cabrero et al. · PubMed · 1987 · 11 citations

Rows per page

1–4 of 4